1. Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells
   Shilpi Singh et al, 2023, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
2. Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification
   Zhicheng Deng et al, 2022, Frontiers in Pharmacology CrossRef
3. Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
   Ulla Simanainen et al, 2015, Hormones and Cancer CrossRef
4. In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors
   Ankita Sahu et al, 2023, DARU Journal of Pharmaceutical Sciences CrossRef
5. Triple Negative Breast Cancer: Molecular Classification, Prognostic Markers and Targeted Therapies
   Narges Jafarzadeh et al, 2015, Razavi International Journal of Medicine CrossRef
6. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
   Maryam Nakhjavani et al, 2019, Journal of Breast Cancer CrossRef
7. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study
   Christina A. Clarke et al, 2017, Breast Cancer Research CrossRef
8. Enhanced characterization of breast cancer phenotypes using Raman micro-spectroscopy on stainless steel substrate
   Giju Thomas et al, 2023, Analytical Methods CrossRef
9. Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward
   Mohammed Alaouna et al, 2023, Plants CrossRef
10. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis
    Honor J. Hugo et al, 2015, Journal of Mammary Gland Biology and Neoplasia CrossRef
11. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
    Mousumi Majumder et al, 2018, International Journal of Molecular Sciences CrossRef
12. Role of Natural Stilbenes in the Prevention of Cancer
    J. Antoni Sirerol et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
13. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells
    Madhu Tanya Singh et al, 2024, Journal of Drug Targeting CrossRef
14. Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts
    Balaji Krishnamachary et al, 2017, Oncotarget CrossRef
15. Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer
    Helena Costa et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
16. Recent Progress in Triple Negative Breast Cancer Research
    Fatima Zahra Mouh et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
17. Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer
    Haechan Lee et al, 2023, PLOS ONE CrossRef
18. Association between shortage of energy supply and nuclear gene mutations leading to carcinomatous transformation
    JIANPING DU, 2016, Molecular and Clinical Oncology CrossRef
19. Do Olive and Fish Oils of the Mediterranean Diet Have a Role in Triple Negative Breast Cancer Prevention and Therapy? An Exploration of Evidence in Cells and Animal Models
    Micah G. Donovan et al, 2020, Frontiers in Nutrition CrossRef
20. Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer
    Martina Dameri et al, 2021, International Journal of Molecular Sciences CrossRef
21. Triple Negative Breast Cancer: Molecular Classification, Prognostic Markers and Targeted Therapies
    Narges Jafarzadeh et al, 2015, Razavi International Journal of Medicine CrossRef
22. Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
    Guillermo Antonio De Paz Linares et al, 2021, Cancers CrossRef
23. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice
    Chih-Hung Guo et al, 2021, Marine Drugs CrossRef